These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 38960788
1. Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022. Shanmugasundaram D, Viswanathan R, Winter AK, Agarwal A, Roychowdhury B, Muliyil D, Prasad GRV, Pushpalatha K, Gowda M, Singh P, Priyasree J, Bonu R, Jha S, Kumar Jena S, Jain S, Suri V, Hebbale V, Jain A, Mary Abraham A, Mishra B, Kumar Pati B, Biswas D, Pratkeye D, Ashok M, Singh MP, Dhodapkar R, Ray R, Gadepalli R, Ratho RK, Rani S, Shukla S, Ali A S, Lakshmi Nag V, Sabarinathan R, Saravana Kumar V, Priya R P, Dwibedi B, Sapkal G, Singh H, Singh K, Tiwari L, Jain M, Mondal N, Sreenivasan P, Mahantesh S, Verma S, Awasthi S, Malik S, Santhanam S, Datta S, Kumar A, Kant Chowdhary B, Khera D, Jain M, Kumar P, Pati S, Tripathi S, Murhekar M. Vaccine; 2024 Oct 24; 42(24):126077. PubMed ID: 38960788 [Abstract] [Full Text] [Related]
2. Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling. Hachiya M, Vynnycky E, Mori Y, Do HT, Huynh MK, Trinh LH, Nguyen DD, Tran NAT, Hoang TT, Hoang HHT, Vo NDT, Le TH, Ichimura Y, Miyano S, Okawa S, Thandar MM, Yokobori Y, Inoue Y, Mizoue T, Takeda M, Komada K. Int J Infect Dis; 2024 Jul 24; 144():107053. PubMed ID: 38641317 [Abstract] [Full Text] [Related]
3. Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019-20. Shanmugasundaram D, Awasthi S, Dwibedi B, Geetha S, Jain M, Malik S, Patel B, Singh H, Tripathi S, Viswanathan R, Agarwal A, Bonu R, Jain S, Jena SK, Priyasree J, Pushpalatha K, Ali S, Biswas D, Jain A, Narang R, Madhuri S, George S, Kaduskar O, Kiruthika G, Sabarinathan R, Sapakal G, Gupta N, Murhekar MV. PLoS Negl Trop Dis; 2021 Jul 24; 15(7):e0009608. PubMed ID: 34297716 [Abstract] [Full Text] [Related]
4. Estimating the burden of rubella virus infection and congenital rubella syndrome through a rubella immunity assessment among pregnant women in the Democratic Republic of the Congo: Potential impact on vaccination policy. Alleman MM, Wannemuehler KA, Hao L, Perelygina L, Icenogle JP, Vynnycky E, Fwamba F, Edidi S, Mulumba A, Sidibe K, Reef SE. Vaccine; 2016 Dec 12; 34(51):6502-6511. PubMed ID: 27866768 [Abstract] [Full Text] [Related]
5. Seroprevalence of rubella in the cord blood of pregnant women and congenital rubella incidence in Nha Trang, Vietnam. Miyakawa M, Yoshino H, Yoshida LM, Vynnycky E, Motomura H, Tho le H, Thiem VD, Ariyoshi K, Anh DD, Moriuchi H. Vaccine; 2014 Feb 26; 32(10):1192-8. PubMed ID: 24021315 [Abstract] [Full Text] [Related]
6. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey. Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ. Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529 [Abstract] [Full Text] [Related]
7. Congenital Rubella Syndrome Surveillance After Measles Rubella Vaccination Introduction in Yogyakarta, Indonesia. Herini ES, Triono A, Iskandar K, Prasetyo A, Nugrahanto AP, Gunadi. Pediatr Infect Dis J; 2021 Dec 01; 40(12):1144-1150. PubMed ID: 34609101 [Abstract] [Full Text] [Related]
8. Targeting rubella for elimination. Taneja DK, Sharma P. Indian J Public Health; 2012 Dec 01; 56(4):269-72. PubMed ID: 23354136 [Abstract] [Full Text] [Related]
9. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan. Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW. Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764 [Abstract] [Full Text] [Related]
10. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign. Honarvar B, Moghadami M, Moattari A, Emami A, Odoomi N, Bagheri Lankarani K. PLoS One; 2013 Jul 17; 8(1):e55043. PubMed ID: 23383049 [Abstract] [Full Text] [Related]
11. The risk factors of exposure to rubella among pregnant women in Zaria 2013. Gubio AB, Mamman AI, Abdul M, Olayinka AT. Pan Afr Med J; 2019 Jul 17; 32(Suppl 1):4. PubMed ID: 30949283 [Abstract] [Full Text] [Related]
12. Seroprevalence of rubella among women of childbearing age in Taiwan after nationwide vaccination. Su SB, Guo HR. Am J Trop Med Hyg; 2002 Nov 17; 67(5):549-53. PubMed ID: 12479561 [Abstract] [Full Text] [Related]
13. Seroprevalence of rubella among Jordanian women of childbearing age. Jarour N, Hayajneh WA, Balbeesi A, Otoom H, Al-Shurman A, Kharabsheh S. Vaccine; 2007 May 04; 25(18):3615-8. PubMed ID: 17280747 [Abstract] [Full Text] [Related]
14. Informing rubella vaccination strategies in East Java, Indonesia through transmission modelling. Wu Y, Wood J, Khandaker G, Waddington C, Snelling T. Vaccine; 2016 Nov 04; 34(46):5636-5642. PubMed ID: 27670077 [Abstract] [Full Text] [Related]
15. Serological statuses of pregnant women in an urban Brazilian population before and after the 2008 rubella immunization campaign. Avila Moura A, Mello MJG, Correia JB. Vaccine; 2016 Jan 20; 34(4):445-450. PubMed ID: 26707222 [Abstract] [Full Text] [Related]
16. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia. Carcelen AC, Mutembo S, Matakala KH, Chilumba I, Mulundu G, Monze M, Mwansa FD, Moss WJ, Hayford K. Am J Trop Med Hyg; 2021 May 03; 104(6):2229-2232. PubMed ID: 33939639 [Abstract] [Full Text] [Related]
17. Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome. He H, Yan R, Tang X, Zhou Y, Deng X, Xie S. BMC Infect Dis; 2016 Nov 30; 16(1):723. PubMed ID: 27899091 [Abstract] [Full Text] [Related]
18. Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy. Marchi S, Viviani S, Montomoli E, Trombetta CM. Hum Vaccin Immunother; 2020 Apr 02; 16(4):895-898. PubMed ID: 31674859 [Abstract] [Full Text] [Related]
19. Developing rubella vaccination policy in Nepal--results from rubella surveillance and seroprevalence and congenital rubella syndrome studies. Upreti SR, Thapa K, Pradhan YV, Shakya G, Sapkota YD, Anand A, Taylor T, Mach O, Reef S, Pattamadilok S, Liyanage J, O'Connor P, Sedai T, Bhandary SR, Partridge J, Schluter W. J Infect Dis; 2011 Jul 02; 204 Suppl 1():S433-8. PubMed ID: 21666196 [Abstract] [Full Text] [Related]
20. Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India. Sharma HJ, Padbidri VS, Kapre SV, Jadhav SS, Dhere RM, Parekh SS, Dudhane AD, Shewale SD, Namjoshi GS. J Infect Dev Ctries; 2011 Dec 13; 5(12):874-81. PubMed ID: 22169787 [Abstract] [Full Text] [Related] Page: [Next] [New Search]